About EPITOPIC
EPITOPIC is a company based in Leipzig (Germany) founded in 2016. EPITOPIC offers products and services including Epitope Fingerprinting and Mimotope Identification. EPITOPIC operates in a competitive market with competitors including Omniome, Benchsci, Tessera Therapeutics, HitGen and Phase Genomics, among others.
- Headquarter Leipzig, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Epitopic Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EPITOPIC
EPITOPIC offers a comprehensive portfolio of products and services, including Epitope Fingerprinting and Mimotope Identification.
Identifies structural epitopes in antibodies through sequence analysis.
Discovers mimotopes for diagnostic and research applications.
Funding Insights of EPITOPIC
Detailed funding history for EPITOPIC
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EPITOPIC
Investment portfolio details for EPITOPIC
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EPITOPIC
Detailed financials for EPITOPIC
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epitopic Comparisons
Peer comparison for EPITOPIC
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EPITOPIC
EPITOPIC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Benchsci, Tessera Therapeutics, HitGen and Phase Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
Detailed competitors of EPITOPIC
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epitopic
Complete news archive for EPITOPIC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EPITOPIC
EPITOPIC was founded in 2016.
EPITOPIC is headquartered in Leipzig, Germany. It is registered at Leipzig, Saxony, Germany.
Michael Szardenings is the current CEO of EPITOPIC.
EPITOPIC was founded in 2016 through collaboration between PolyQuant GmbH and the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig, Germany. Services in cell therapy and antibody development are offered, incorporating trinucleotide DNA libraries, peptide phage display, next-generation sequencing, and data analysis methods. Binding sites for antibodies are precisely identified, along with acceptable modifications. Operations are based in Leipzig, focusing on the biotechnology sector.
EPITOPIC's top competitors include Tessera Therapeutics, Novogene Corporation and Antiverse.
EPITOPIC offers Epitope Fingerprinting and Mimotope Identification.